Silver Book Fact

Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.

Lam, Byron L., D. Diane Zheng, Evelyn P. Davila, Kristopher L. Arheart, Manuel A. Ocasio, Kathryn E. McCollister, Alberto J. Caban-Martinez, and David J. Lee. Trends in Glaucoma Medication Expenditures. Arch Ophthalmol. October 2011; 124(1): 12-9. http://archopht.ama-assn.org/cgi/content/abstract/129/10/1345

Reference

Title
Trends in Glaucoma Medication Expenditures
Publication
Arch Ophthalmol
Publication Date
October 2011
Authors
Lam, Byron L., D. Diane Zheng, Evelyn P. Davila, Kristopher L. Arheart, Manuel A. Ocasio, Kathryn E. McCollister, Alberto J. Caban-Martinez, and David J. Lee
Volume & Issue
Volume 124, Issue 1
Pages
12-9
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • An estimated 4,195,966 Americans age 40 and older have vision impairment and blindness—1,288,275 are blind and 2,907,691 have vision impairment.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with age-related macular degeneration (AMD) is $575 million.  
  • Visual impairment and blindness cause an annual health utility loss of approximately $10.5 billion. This figure measures lost quality of life when a disease has little or no short-term impact…  
  • For those at high risk of advanced AMD, high dGI (dietary glycemic index) diets increased the risk of developing advanced AMD by 17%.  
  • Estimated Specific Prevalence Rates for Visual Impairment and Blindness